発表論文

2025年度（2025-2026）

1. Nelson C, Kauffman K,  Sakai S, Newbolt T, Buchanan J, Foreman T, Walker A, Gomez F, Fleegle J, Herbert R, Hill T, Turan S, Mayer-Barber D, Johnson R, Via L, Barber D. 
   “Glucocorticoids suppresses early lung inflammation and impair control of SARS-CoV-2 in non-human primates”
   PLoS One. 21:e0342849. (2026 Mar 10),
   DOI: 10.1371/journal.pone.0342849
2. Collins J, Wassie L, Bobosha K, Gandhi N, Liu K, Day S, Regngarajan J, Kemper R, Lau M, Nellis M, Nizam A, Maner-Smith K, Ortlund E, Sakai S, Kauffman K, Magee M, Jones D, Ernst J, Barber D, Blumberg H. 
   “Infection with Mycobacterium tuberculosis depletes host fatty acids in humans and non-human primates”
   eBioMedicine. 125:106193. (2026 Feb 27),
   DOI: 10.1016/j.ebiom.2026.106193
3. Torigoe S, Salie S, Keeton R, Aylan B, Appelmelk BJ, Williams DL, Lowman DW, Sugiki T, Matsumoto S, Kawano A, Mizuno S, Matsuo K, Søndergaard JN, Wing JB, Hoft M, Shoesmith R, Ndengane M, Coussens AK, Willment JA, Gutierrez MG, Hoving JC, Yamasaki S, Brown GD.
   “Mycobacterial α-glucans hijack Dectin-1 to facilitate intracellular bacterial survival”
   Sci Immunol. 11:eadw0732, (2026 Jan 9),
   DOI: 10.1126/sciimmunol.adw0732
4. Nelson C, Kauffman K, Osum K, Sakai S, Buchanan J, Chanchu J, Cohen M, Laux J, Dougi I, Barrows K, Anidi I, Linderstam Arlehamn C, Sette A, Walker A, Shamsaddini A, Lack J, Ernst J, Feng C, Via L, Fennelly K, Carr S, Barber D.
   “Mycobacterium tuberculosis peptide-specific T cells in pulmonary granulomas display broad effector functions”
   iScience. 28:114034. (2025 Nov 12),
   DOI: 10.1016/j.isci.2025.114034
5. Takeuchi H, Mizuno S, Matsuo K.
   “Efficient recombinant protein secretion in Mycobacterium smegmatis: A valuable platform for protein production involved in biomedical development targeting mycobacterial diseases”
   J Biotechnol. 409:148-156,  (2025 Nov 1),
   DOI: 10.1016/j.jbiotec.2025.10.013
6. Kawano A, Asaka MN, Kawano M, Sekijima H, Sakai-Sugino K, Komada H, Yamakawa N, Horibata S, Matsuo K, O’Brien M, Nosaka T, Yasutomi Y.
   “Development of a Novel Mucosal Vaccine Vector Derived From Human Parainfluenza Virus Type 2 and Its Efficacy as a SARS-CoV-2 Vaccine by Intratracheal Administration Using Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2”
   Genes Cells. 30:e70058. (2025 Oct 27),
   DOI: 10.1111/gtc.70058
7. Collins J, Bobosha K, Narayanan N, Gandhi N, Day S, Regngarajan J, Kemper R, Lau M, Nellis M, Tukvandze N, Shah N, Brust J, Nizam A, Ismail N, Kauffman K, Sakai S, Jones D, Barber D, Ziegler T, Ernst J, Blumberg H, Wassie L, TBRU-ASTRa Study Group.
   “A plasma metabolic signature to diagnose pulmonary tuberculosis and monitor treatment response”
   J Infec Dis. 232:578-587,  (2025 Sep 15),
   DOI: 10.1093/infdis/jiaf240
8. Cai Z, Kozai M, Mita H, Takeuchi H, Mizuno S, Matsuo K, Takada K.
   “Retinoic acid receptor-related orphan receptor α regulates bystander activation of memory CD8+ T cells”
   Front Immunol. 16:1647746. (2025 Aug 14),
   DOI: 10.3389/fimmu.2025.1647746

2023年度（2023-2024）

1. Wang S, Kozai M, Hiraishi M, Rubel MZU, Ichii O, Inaba1 M, Matsuo K, Takada K.
   “Roles of tumor necrosis factor-like ligand 1A in γδT-cell activation and psoriasis pathogenesis”
   Front. Immunol. 15:1340467. (2024 Jan 29)
   DOI: 10.1016/j.ebiom.2023.104950
2. Mizuno S, Chuma Y, Shibuya Y, Horibata S, Baba T, Yokokawa E, and Matsuo K.
   “Culture filtrate proteins from BCG act as adjuvants for cytotoxic T lymphocyte induction”
   Front Immunol. 14:1271228. (2023 Oct 18)
   DOI: 10.3389/fimmu.2023.1271228